Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks

Journal of the National Medical Association

Volumn 91, Issue 1, 1999, Pages 40-48

  Prisant, L Michael ^a   Neutel, Joel M ^b   Ferdinand, Keith ^b   Papademetriou, Vasilios ^b   DeQuattro, Vincent ^b   Hall, W Dallas ^b   Weir, Matthew R ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NONE

Author keywords

Amlodipine; Bisoprolol; Enalapril; Hydrochlorothiazide; Hypertension

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BISOPROLOL; ENALAPRIL; HYDROCHLOROTHIAZIDE;

AGED; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; ETHNOLOGY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MULTICENTER STUDY; NEGRO; RANDOMIZED CONTROLLED TRIAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AMLODIPINE; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BISOPROLOL; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0032602902     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
2. Chalmers J. The place of combination therapy in the treatment of hypertension in 1993. Clin Exp Hypertens. 1993;15:1299-1313.
3. Epstein M, Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch Intern Med. 1996;156:1969-1978.
4. Waeber B. Brunner HR. Main objectives and new aspects of combination treatment of hypertension. J Hypertens Suppl. 1995;13:S15-S19.
5. Kaplan NM. Implications for cost-effectiveness. Combination therapy for systemic hypertension. Am J Cardiol. 1995;76:595-597.
6. Moser M, Prisant LM. Low-dose combination therapy in hypertension. Am Fam Physician. 1997;56:1275-1282.
7. Prisant LM, Doll NC. Hypertension: the rediscovery of combination therapy. Geriatrics. 1997;52:28-38.
8. Frishman WH, Bryzinski BS, Coulson LR, et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med. 1994;154:1461-1468.
9. Chrysant SG. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group. Arch Intern Med. 1994;154:737-743.
10. Frishman WH, Burris JF, Mroczek WJ, et al. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol. 1995;35:182-188.
11. MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components. Arch Intern Med. 1996;156:278-285.
12. Fenichel RR, Lipicky RJ Combination products as first-line pharmacotherapy. Arch Intern Med. 1994;154:1429-1430.
13. Saunders E, Neutel J. A new antihypertensive strategy for black patients: low-dose multimechanism therapy. J Natl Med Assoc. 1996;88:171-175.
14. Prisant LM, Mensah GA. Use of beta-adrenergic receptor blockers in blacks. J Clin Pharmacol. 1996;36:867-873.
15. Gavras H. A multicenter trial of enalapril in the treatment of essential hypertension. Clin Ther. 1986;9:24-38.
16. Saunders E, Weir MR, Kong BW, et al. A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med. 1990;150:1707-1713.
17. Weir MR, Gray JM, Paster R, Saunders E. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group. Hypertension. 1995;26:124-130.
18. Julius S. Amlodipine in hypertension: an overview of the clinical dossier. J Cardiovasc Pharmacol. 1988;12:S27-S33.
19. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993;328:914-921.
20. Prisant LM, Weir MR, Papademetriou V, et al. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J. 1995;130:359-366.
21. Neutel JM, Rolf CN, Valentine SN, Li J, Lucas C, Marmorstein BL. Low-dose combination therapy as first line treatment of mild-to-moderate hypertension: the efficacy and safety of bisoprolol/HCTZ versus amlodipine, enalapril, and placebo. Cardiovascular Reviews Reports. 1996;17:33-45.
22. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
23. Oster JR, Epstein M. Fixid-dose combination medications for the treatment of hypertension: a critical review. Journal of Clinical Hypertension. 1987;3:278-93.